Table 1 Descriptive results (main aspects)
From: Regional differences in health care of patients with inflammatory bowel disease in Germany
Crohn Disease (CD) | Ulcerative Colitis (UC) | Total | ||
|---|---|---|---|---|
n = 9282 | n = 12,489 | n = 21,771 | ||
Regular specialist visits | 20 % | 22 % | 21 % | |
Medication | ||||
Permanent steroid therapy | Received medication | 28 % | 17 % | 22 % |
With continuous specialist supporta | 32 % | 37 % | 34 % | |
Permanent immunosuppressive therapy | Received medication | 22 % | 11 % | 16 % |
With continuous specialist supporta | 34 % | 38 % | 36 % | |
TNF-α inhibitors therapy | Received medication | 7 % | 2 % | 4 % |
With continuous specialist supporta | 50 % | 51 % | 50 % | |
Surveillance colonoscopy (UC patients aged ≥ 50 years (n = 6664)) | / | 9 % | / | |
IBD-related hospitalization | 13 % | 5 % | 9 % | |